A Descriptive Study on Patients With Bipolar Disorder in Rwanda
研究概览
详细说明
The aim is to provide a comprehensive assessment regarding the service provision and the accessibility to intensive mental health care in Rwanda for patients with bipolar disorder.
Knowing about the barriers to treatment, risk and protective factors as well as the current treatment offered for patients with bipolar disorder is essential for the development of therapeutic approaches and improvement in access to care. Up to now, no data on characteristics of patients with bipolar disorder in Rwanda and related risk and protective factors is available. For this purpose, all outpatients with bipolar disorder in Rwanda age > 18 years, will over a 1-year period be invited to participate in a survey on their experience living with bipolar disorder in Rwanda. Moreover, patients and relatives will be invited for in-depth interviews to explore their perceptions and experiences with the mental health system. Health care providers will meet for focus discussions on to assess the experience, knowledge and practice of caregiving for individuals with bipolar disorder.
研究类型
注册 (预期的)
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- A diagnosis of Bipolar Disorder type I or II that meets DSM-V diagnostic criteria
- Age ≥ 18 years
Exclusion Criteria:
- None
学习计划
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diagnoses
大体时间：1 year
|
Psychiatric diagnoses including both primary diagnosis, secondary diagnosis and somatic comorbidity.
|
1 year
|
|
Diagnostic delay
大体时间：1 year
|
Age of individual at onset of symptoms and age when diagnosed with bipolar disorder.
|
1 year
|
|
Number of previous psychiatric hospitalisations
大体时间：1 year
|
Numerical value of the previous psychiatric hospitalisations.
|
1 year
|
|
Number of previous crises
大体时间：1 year
|
Numerical value of the previous crises defined as an episode of depression or mania or hypomania.
|
1 year
|
|
Types of medical treatment provided
大体时间：1 year
|
What type of medical treatment is provided, including brand name, administration and dosage.
|
1 year
|
|
Medical Adherence
大体时间：1 year
|
Medication Adherence Rating Scale (MARS) will be used to assess beliefs and barriers to medication adherence.
Total scores on the MARS may range between 0 and 10, with a higher score indicating better medication adherence.
|
1 year
|
|
The referral pathways
大体时间：1 year
|
Who initiated the first contact, who did you seek for help, what kind of help was provided, percent of patients who came in contact with traditional leaders.
|
1 year
|
|
Degree of internal stigma
大体时间：1 year
|
Internalized Stigma of Mental Illness Inventory - 9-item Version (ISMI-9) will be used to assess self-stigma.
The resulting score should range from 1 to 4. A score ranging between 1.00-2.50:
does not report high internalized stigma vs. a score ranging between 2.51-4.00:
indicating high internalized stigma.
|
1 year
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- AUUR2020DKRW_3
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.